SEC Form 4 · accession 0001209191-15-009659
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 8:32 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 3, 2015 | J | 7,373 | $0.00 | A | 7,504 | I | Nick Leschly 2001 Trust |
| Common StockF2,F3 | holding | — | — | — | 246,249 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 7373 shares received as a pro rata distribution in kind from Third Rock Ventures GP, L.P.
- F2Includes 727 shares acquired under the bluebird bio employee stock purchase plan on January 30, 2015.
- F3Excludes 131 shares previously owned directly which were contributed to the Nick Leschly 2001 Trust.